Michael J. Fox Foundation

Purdue Team Identifies Urinary Protein Markers for Parkinson's Disease
Premium

In work supported by the Michael J. Fox Foundation, the researchers identified protein markers for the condition in extracellular vesicles collected from urine.

Erisyon Wins $189K Michael J. Fox Foundation Grant for Protein Biomarker Discovery

Erisyon will use its single-molecule protein sequencing technology to detect and validate biomarkers for early detection of Parkinson's disease.

New Parkinson's Disease RNA-Seq Dataset Enables Search for Disease Biomarkers
Premium

The Michael J. Fox Foundation-led project aims to lead researchers to new insights about biomarkers indicating Parkinson's disease progression.

NIH Launches Parkinson's Disease Research Partnership

The partnership includes biopharmaceutical, life science, and non-profit organizations, as well as several US government agencies.

Michael J. Fox Foundation Grants $4M to 23andMe for New Parkinson's Disease Collaboration

The study will provide researchers, drugmakers, regulators, and payors with insight into the genetics of the disease and experience of the patients.

Oct 4, 2017

GNS Healthcare's Machine Learning Platform Leads to Novel Parkinson's Gene Discovery
Premium

Apr 12, 2016

STSI Launches Study to Improve Screening Accuracy for Parkinson's Disease
Premium

Oct 3, 2014

Michael J. Fox Foundation Funds GVSU Research into Parkinson's Biomarker

Jun 27, 2012

KineMed Receives $1.2M from Michael J. Fox Foundation for Parkinson's Biomarkers

Jan 25, 2012

Lucigen Receives $187K Grant from Michael J. Fox Foundation

Jun 24, 2011

23andMe-Led Team Reports on Findings from Web-Based Parkinson's GWAS

Jun 3, 2011

Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
Premium

Jul 6, 2010

Michael J. Fox Foundation Gives $1.1M for Parkinson's Biomarker Development

Oct 1, 2009

Sigma-Aldrich to Develop Parkinson's Models

Mar 18, 2009

Snippets: Mar 18, 2009
Premium

Mar 17, 2009

Short Reads: Mar 17, 2009
Premium

Mar 13, 2009

23andMe-Led Team Offers Program to Enroll Parkinson's Patients

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.